1. Home
  2. ELTX vs TAYD Comparison

ELTX vs TAYD Comparison

Compare ELTX & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • TAYD
  • Stock Information
  • Founded
  • ELTX 2011
  • TAYD 1955
  • Country
  • ELTX United States
  • TAYD United States
  • Employees
  • ELTX N/A
  • TAYD N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • TAYD Industrial Machinery/Components
  • Sector
  • ELTX Health Care
  • TAYD Industrials
  • Exchange
  • ELTX Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • ELTX 121.7M
  • TAYD 96.0M
  • IPO Year
  • ELTX N/A
  • TAYD N/A
  • Fundamental
  • Price
  • ELTX $5.57
  • TAYD $36.95
  • Analyst Decision
  • ELTX Strong Buy
  • TAYD
  • Analyst Count
  • ELTX 2
  • TAYD 0
  • Target Price
  • ELTX $9.50
  • TAYD N/A
  • AVG Volume (30 Days)
  • ELTX 34.1K
  • TAYD 19.2K
  • Earning Date
  • ELTX 05-19-2025
  • TAYD 03-28-2025
  • Dividend Yield
  • ELTX N/A
  • TAYD N/A
  • EPS Growth
  • ELTX N/A
  • TAYD 1.48
  • EPS
  • ELTX N/A
  • TAYD 2.50
  • Revenue
  • ELTX N/A
  • TAYD $42,796,782.00
  • Revenue This Year
  • ELTX N/A
  • TAYD N/A
  • Revenue Next Year
  • ELTX N/A
  • TAYD N/A
  • P/E Ratio
  • ELTX N/A
  • TAYD $14.00
  • Revenue Growth
  • ELTX N/A
  • TAYD N/A
  • 52 Week Low
  • ELTX $3.34
  • TAYD $29.50
  • 52 Week High
  • ELTX $11.45
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 51.02
  • TAYD 70.42
  • Support Level
  • ELTX $4.85
  • TAYD $30.53
  • Resistance Level
  • ELTX $5.75
  • TAYD $35.59
  • Average True Range (ATR)
  • ELTX 0.49
  • TAYD 1.44
  • MACD
  • ELTX 0.14
  • TAYD 0.60
  • Stochastic Oscillator
  • ELTX 70.28
  • TAYD 87.38

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: